bromodeoxyuridine has been researched along with Disease Exacerbation in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (13.64) | 18.2507 |
| 2000's | 31 (70.45) | 29.6817 |
| 2010's | 5 (11.36) | 24.3611 |
| 2020's | 2 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, N; Gu, K; Hu, J; Ji, Q; Li, Q; Ren, J; Sui, H; Wang, Y; Yang, L; Zhang, B; Zhang, L; Zhou, L | 1 |
| Borchman, D; Cvm, NK; Gaddipati, S; Kasetti, RB; Li, Q; Lu, Q; Zhang, Y | 1 |
| Singh, S | 1 |
| Cao, W; Chen, W; Liu, J; Xu, L; Zhang, C | 1 |
| Aubert, I; Maliszewska-Cyna, E; Xhima, K | 1 |
| Hattiangady, B; Rao, MS; Shetty, AK | 1 |
| Cakiroglu, M; Caldeira, M; Laywell, ED; Levkoff, LH; Mariani, CL; Marshall, GP; Reynolds, BA; Ross, HH; Streit, WJ | 1 |
| Barker, RA; Decressac, M; Gaillard, A; Tyers, P; Wright, B | 1 |
| Ajami, B; Bennett, JL; Krieger, C; McNagny, KM; Rossi, FM | 1 |
| Kataki, A; Marie, B; Martinet, N; Martinet, Y; Piet, M; Scheid, P; Vignaud, JM | 1 |
| Esaki, M; Fujiwara, H; Fujiwara, T; Goto, K; Hayakawa, K; Kawase, Y; Koda, M; Kosai, K; Li, Y; Maruyama, R; Minatoguchi, S; Mizuguchi, H; Nagano, S; Okada, H; Takahashi, T; Takemura, G; Yuge, K | 1 |
| Kawamori, T; Sugimura, T; Uchiya, N; Wakabayashi, K | 1 |
| Kuwano, H; Kuwano, M; Mochida, Y; Taguchi, K; Taniguchi, S; Tsuneyoshi, M; Tsuzuki, T; Wada, M | 1 |
| Fu, VX; Jarrard, DF; Schwarze, SR | 1 |
| Bhide, PG; Finklestein, SP; Moskowitz, MA; Sugimori, H; Wada, K | 1 |
| Ichijo, H; Iwao, H; Izumi, Y; Izumiya, Y; Kim, S; Koyama, H; Matsuzawa, A; Nishizawa, Y; Yoshida, K; Yoshikawa, J; Yoshiyama, M | 1 |
| Doi, K; Fukushima, S; Mitsuhashi, M; Moku, M; Morimura, K; Salim, EI; Shen, J; Wanibuchi, H; Wei, M | 1 |
| Doan, NB; Faulkner, JR; Herrmann, JE; Sofroniew, MV; Tansey, KE; Woo, MJ | 1 |
| Arteaga, CL; Dumont, N; Koh, Y; Ueda, Y; Wang, S; Yi, JY | 1 |
| Brown, M; Pajoohesh-Ganji, A; Pal-Ghosh, S; Stepp, MA | 1 |
| Bai, XF; Joshi, PS; Li, O; Liu, Y; Wang, Y; Zhang, H; Zheng, P; Zheng, X; Zhou, Q | 1 |
| Tu, X; Wang, CC | 1 |
| Allison, DB; Axthelm, MK; Daly, LM; Hagen, SI; Kodama, T; Lifson, JD; Lum, R; Maino, VC; Piatak, M; Picker, LJ; Reed-Inderbitzin, EF; Siess, DC; Sylwester, AW; Walker, JM; Wang, C | 1 |
| Date, I; Kobashikawa, S; Nowakowski, RS; Sekiguchi, M; Takagi, K; Takagi, N; Takeo, S; Tanaka, O; Torigoe, K; Yamato, I | 1 |
| Fujishita, A; Hiraki, K; Ishimaru, T; Khan, KN; Kitajima, M; Masuzaki, H; Matsuyama, T; Sekine, I | 1 |
| Anderson, MA; Bowman, M; Deb, S; Deb, SP; Hassan, S; Miles, MF; Scian, MJ; Stagliano, KE | 1 |
| Garcia, AJ; Lawson, DA; Wang, S; Witte, ON; Wu, H; Wu, M | 1 |
| Adamczyk, A; Gasinska, A; Glinski, B; Krzyszkowski, T; Niemiec, J; Skolyszewski, J; Zabek, M | 1 |
| Barber, JA; Barber, NJ; Martin, FL; Morris, JD; Muir, GH; Pramanik, R; Zhang, X; Zhu, G | 1 |
| Chen, Q; Choi, SH; Nakajima, A; Sisodia, SS; Tang, YP; Xiong, X | 1 |
| Bátiz, LF; Jiménez, AJ; Páez, P; Pérez-Fígares, JM; Roales-Buján, R; Rodríguez, EM; Rodríguez, S; Rodríguez-Pérez, LM | 1 |
| Ferrer-Alcon, M; Kato, AC; Madani, R; Perrin, FE; Winkler-Hirt, C | 1 |
| Chandler, KL; Davis, RL; Hoshino, T; Ito, S; Lamborn, K; Malec, MK; Prados, MD; Wilson, CB; Wynne, J | 1 |
| Asamoto, M; Baba, H; Hakoi, K; Iwahori, Y; Iwase, T; Matsumoto, K; Nagao, S; Nishida, Y; Tsuda, H; Yamaguchi, S | 1 |
| Baisch, H; Fack, H; Otto, U | 1 |
| Chapman, W; Fyles, AW; Li, Y; Pintilie, M; Rajaraman, MM; Tsang, RW; Wong, CS | 1 |
| Bruner, JM; Groves, MD; Hess, K; Jaeckle, KA; Kyritsis, AP; Levin, VA; Maor, MH; Meyers, C; Peterson, P; Sawaya, RE; Yung, WK | 1 |
| Buckner, JC; Cascino, TL; Curran, WJ; Davis, R; Greenberg, HS; Gutin, P; Phillips, T; Prados, MD; Sandler, H; Schultz, C; Scott, C; Urtasun, R | 1 |
| Smith, AM; Watson, SA | 1 |
| Dell'Acqua, G; Dzau, VJ; Ehsan, A; Mann, MJ | 1 |
| Tabas, I | 1 |
| Fukushima, S; Hori, T; Kaneko, M; Morimura, K; Nishikawa, A; Nishikawa, T; Osugi, H; Takada, N; Wanibuchi, H | 1 |
| Foroudi, F; Lincoff, AM; Marso, SP; Park, SH; Topol, EJ; Zhou, Z | 1 |
| Hanahan, D; Lopez, T | 1 |
4 trial(s) available for bromodeoxyuridine and Disease Exacerbation
| Article | Year |
|---|---|
Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
Topics: Adult; Age Factors; Aged; Brain Neoplasms; Bromodeoxyuridine; Cell Proliferation; Combined Modality Therapy; Disease Progression; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Oxygen; Ploidies; Prognosis; Sensitivity and Specificity; Staining and Labeling; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2006 |
Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.
Topics: Aged; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bromodeoxyuridine; Carotenoids; Disease Progression; DNA, Neoplasm; Dose-Response Relationship, Drug; Epithelial Cells; Follow-Up Studies; Humans; Lycopene; Male; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Regression Analysis; Treatment Outcome | 2006 |
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bromodeoxyuridine; Cognition; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Radiation-Sensitizing Agents; Reoperation; Vincristine | 1999 |
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Chemotherapy, Adjuvant; Disease Progression; Female; Humans; Lomustine; Male; Middle Aged; Procarbazine; Proportional Hazards Models; Radiation-Sensitizing Agents; Survival Analysis; Vincristine | 1999 |
40 other study(ies) available for bromodeoxyuridine and Disease Exacerbation
| Article | Year |
|---|---|
YYFZBJS ameliorates colorectal cancer progression in Apc
Topics: Adenomatous Polyposis Coli Protein; Animals; Bacteroides fragilis; Bromodeoxyuridine; Carcinogenesis; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; Disease Progression; Drugs, Chinese Herbal; Gastrointestinal Microbiome; HCT116 Cells; Humans; Immunity; Ki-67 Antigen; Leukocytes, Mononuclear; Lymph Nodes; Mice; Mice, Inbred C57BL; Mucous Membrane; Proliferating Cell Nuclear Antigen; RNA, Messenger; Spleen; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 2020 |
Heterozygous Loss of Yap1 in Mice Causes Progressive Cataracts.
Topics: Adaptor Proteins, Signal Transducing; Animals; Blotting, Western; Bone Morphogenetic Protein Receptors; Bromodeoxyuridine; Cataract; Cell Count; Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Disease Progression; Epithelial Cells; Gene Expression Regulation, Developmental; Heterozygote; In Situ Nick-End Labeling; Lens, Crystalline; Mice; Mice, Inbred C57BL; Mice, Knockout; Organogenesis; Real-Time Polymerase Chain Reaction; YAP-Signaling Proteins | 2020 |
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Celecoxib; Cell Line, Tumor; Cell Survival; Disease Progression; Doxorubicin; Humans; Liposomes; Particle Size; Skin Neoplasms; Static Electricity | 2018 |
Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.
Topics: Bromodeoxyuridine; Carcinogenesis; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Proliferation; Cohort Studies; Disease Progression; Extracellular Matrix Proteins; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Humans; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Grading; Nerve Tissue Proteins; RNA, Small Interfering; Sincalide; Tumor Suppressor Proteins | 2015 |
A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Bromodeoxyuridine; Disease Models, Animal; Disease Progression; Exploratory Behavior; Hippocampus; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Physical Conditioning, Animal; Spatial Memory; Time Factors | 2016 |
Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Disease Progression; Embryo, Mammalian; Epilepsy, Temporal Lobe; Fibroblast Growth Factor 2; Hippocampus; Kainic Acid; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Rats; Rats, Inbred F344; Status Epilepticus; Stem Cell Transplantation; Stem Cells; Time Factors | 2008 |
Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Disease Progression; Glioma; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Neoplasms, Experimental; Nucleosides; Rats; Rats, Inbred F344; Time Factors; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Neuropeptide Y modifies the disease course in the R6/2 transgenic model of Huntington's disease.
Topics: Animals; Antimetabolites; Behavior, Animal; Body Weight; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Progression; Female; Hippocampus; Humans; Huntington Disease; Immunohistochemistry; Injections, Intraventricular; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neostriatum; Neuropeptide Y; Postural Balance; Stereotaxic Techniques; Survival Analysis | 2010 |
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool.
Topics: Animals; Bone Marrow Transplantation; Bromodeoxyuridine; Calcium-Binding Proteins; CD11b Antigen; Chemotaxis, Leukocyte; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Green Fluorescent Proteins; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microglia; Monocytes; Myeloablative Agonists; Parabiosis; Receptors, CCR2; Receptors, Interleukin-8A; Severity of Illness Index; Time Factors; Whole-Body Irradiation | 2011 |
Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
Topics: Biomarkers, Tumor; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Disease Progression; DNA Replication; Female; Histocompatibility Testing; HLA Antigens; Humans; Immunoenzyme Techniques; In Situ Hybridization; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages, Alveolar; Male; Middle Aged; Neoplasm Staging | 2002 |
Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Topics: Adenoviridae; Animals; Bromodeoxyuridine; Cell Division; Chronic Disease; Disease Models, Animal; Disease Progression; Genetic Vectors; Hepatocyte Growth Factor; Hepatocytes; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Survival Rate; Time Factors; Transduction, Genetic; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2003 |
Enhancement of colon carcinogenesis by prostaglandin E2 administration.
Topics: Adenocarcinoma; Animals; Apoptosis; Azoxymethane; Bromodeoxyuridine; Carcinogens; Colon; Colonic Neoplasms; Dinoprostone; Disease Progression; DNA Primers; Incidence; Injections, Intraperitoneal; Intestinal Mucosa; Male; Rats; Rats, Inbred F344; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Bromodeoxyuridine; Cell Division; Cell Movement; Disease Progression; DNA Damage; Drug Resistance, Multiple; Enterocytes; Female; Genes, APC; Immunoenzyme Techniques; Intestinal Mucosa; Intestinal Polyps; Intestines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic | 2003 |
Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Survival; Chaperonins; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Disease Progression; Drosophila Proteins; Enzyme Activation; Epithelial Cells; Humans; Male; Molecular Chaperones; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf | 2003 |
Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats.
Topics: Animals; Antigens, Differentiation; Brain; Brain Ischemia; Bromodeoxyuridine; Cell Count; Dentate Gyrus; Disease Models, Animal; Disease Progression; Doublecortin Protein; Fibroblast Growth Factor 2; Immunohistochemistry; Injections, Intraventricular; Lateral Ventricles; Male; Rats; Rats, Sprague-Dawley; Stem Cells | 2003 |
Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
Topics: Adenoviridae; Animals; Bromodeoxyuridine; Carotid Arteries; Carotid Artery Injuries; Cell Division; Cell Movement; Cells, Cultured; Disease Models, Animal; Disease Progression; Enzyme Activation; Gene Transfer Techniques; Genes, Dominant; Hyperplasia; Male; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Rats; Tunica Intima; Tunica Media | 2003 |
Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Benzenesulfonates; Bromodeoxyuridine; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Isoenzymes; Male; Oxazoles; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344 | 2003 |
Reactive astrocytes protect tissue and preserve function after spinal cord injury.
Topics: Animals; Antiviral Agents; Astrocytes; Blood-Brain Barrier; Bromodeoxyuridine; Cell Division; Disease Models, Animal; Disease Progression; Ganciclovir; Glial Fibrillary Acidic Protein; Inflammation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Nerve Crush; Neurons; Oligodendroglia; Recombinant Fusion Proteins; Recovery of Function; Spinal Cord Injuries; Thymidine Kinase; Transgenes; Wounds, Stab | 2004 |
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Topics: Actins; Activin Receptors, Type I; Adenoviridae; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blotting, Northern; Breast Neoplasms; Bromodeoxyuridine; Butadienes; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Cell Movement; Chromones; Disease Progression; DNA, Complementary; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Humans; Imidazoles; Immunoblotting; Integrin beta1; Ligands; Luminescent Proteins; Microscopy, Fluorescence; Models, Genetic; Morpholines; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Precipitin Tests; Protein Serine-Threonine Kinases; Pseudopodia; Pyridines; rac1 GTP-Binding Protein; Receptor, ErbB-2; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Retroviridae; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta; Trastuzumab; Wound Healing | 2004 |
A mouse model for the study of recurrent corneal epithelial erosions: alpha9beta1 integrin implicated in progression of the disease.
Topics: Animals; Bromodeoxyuridine; Cell Division; Corneal Diseases; Corneal Injuries; Debridement; Disease Models, Animal; Disease Progression; Epithelium, Corneal; Female; Fluorescent Antibody Technique, Indirect; Integrin alpha Chains; Integrin alpha3beta1; Integrin alpha6beta4; Male; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Recurrence; Tenascin; Up-Regulation; Wound Healing | 2004 |
CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Antigens, CD; Apoptosis; Bone Marrow; Bromodeoxyuridine; CD24 Antigen; Central Nervous System; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Immunohistochemistry; Lymphocyte Activation; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroglia; T-Lymphocytes; Time Factors | 2004 |
Coupling of posterior cytoskeletal morphogenesis to the G1/S transition in the Trypanosoma brucei cell cycle.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Nucleus; Cell Separation; Coloring Agents; Cytoskeleton; Disease Progression; DNA; DNA, Complementary; DNA, Kinetoplast; Flagella; Flow Cytometry; G1 Phase; Indoles; Microscopy, Fluorescence; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; S Phase; Time Factors; Trypanosoma brucei brucei; Tubulin | 2005 |
Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Disease Progression; Flow Cytometry; Fluorescent Antibody Technique; Immunologic Memory; Macaca mulatta; Male; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Species Specificity | 2004 |
Time course and sequence of pathological changes in the cerebellum of microsphere-embolized rats.
Topics: Animals; Bromodeoxyuridine; Cerebellum; Dementia, Multi-Infarct; Disease Models, Animal; Disease Progression; Male; Microspheres; Neuroglia; Neurons; Purkinje Cells; Rats; Rats, Wistar; Stroke; Time Factors | 2005 |
Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis.
Topics: Antimetabolites; Bromodeoxyuridine; Cell Proliferation; Culture Media; Disease Progression; Endometriosis; Endometrium; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Hepatocyte Growth Factor; Humans; Immunoglobulin G; Immunohistochemistry; Inflammation; Interleukin-6; Proto-Oncogene Proteins c-met; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Tumor Necrosis Factor-alpha; Vimentin | 2005 |
Tumor-derived p53 mutants induce NF-kappaB2 gene expression.
Topics: Adenoviridae; Bromodeoxyuridine; Cell Line, Tumor; Cell Nucleus; Cloning, Molecular; Disease Progression; DNA, Complementary; Etoposide; Exons; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mutation; NF-kappa B; NF-kappa B p52 Subunit; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; RNA; RNA, Small Interfering; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2005 |
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Separation; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Flow Cytometry; Gene Deletion; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Ki-67 Antigen; Kinetics; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Neoplasms; Phosphoproteins; Prostatic Neoplasms; PTEN Phosphohydrolase; Stem Cells; Time Factors; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins | 2006 |
Adult neurogenesis is functionally associated with AD-like neurodegeneration.
Topics: Age Factors; Alzheimer Disease; Animals; Bromodeoxyuridine; Cell Count; Cell Proliferation; Dentate Gyrus; Disease Models, Animal; Disease Progression; Mice; Mice, Knockout; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Presenilin-1; Presenilin-2 | 2008 |
Patterned neuropathologic events occurring in hyh congenital hydrocephalic mutant mice.
Topics: Animals; Animals, Newborn; Brain; Bromodeoxyuridine; Disease Models, Animal; Disease Progression; Embryo, Mammalian; Ependyma; Female; Gene Expression Regulation, Developmental; Hydrocephalus; Male; Mice; Mice, Mutant Strains; Microfilament Proteins; Nerve Tissue Proteins; Pregnancy | 2007 |
Low intensity exercise attenuates disease progression and stimulates cell proliferation in the spinal cord of a mouse model with progressive motor neuronopathy.
Topics: Analysis of Variance; Animals; Antibodies; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Models, Animal; Disease Progression; Insulin-Like Growth Factor I; Mice; Mice, Neurologic Mutants; Motor Neuron Disease; Motor Neurons; Muscle Fibers, Skeletal; Physical Conditioning, Animal; Spinal Cord | 2008 |
Proliferative potential and prognostic evaluation of low-grade astrocytomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Survival Analysis; Tumor Cells, Cultured | 1994 |
Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin 32 expression.
Topics: Animals; Bromodeoxyuridine; Cell Division; Connexins; Disease Progression; Gap Junction beta-1 Protein; Hepatectomy; Immunohistochemistry; Liver; Liver Neoplasms, Experimental; Male; Phenotype; Rats; Rats, Wistar | 1995 |
Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Division; Disease Progression; DNA, Neoplasm; Drug Implants; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Testosterone; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aneuploidy; Antimetabolites; Apoptosis; Biopsy; Bromodeoxyuridine; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Diploidy; Disease Progression; Female; Flow Cytometry; Forecasting; Humans; Middle Aged; Mitosis; Neoplasm Staging; Prospective Studies; S Phase; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Topics: Adenoma; Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Bromodeoxyuridine; Cancer Vaccines; Colorectal Neoplasms; Cytoskeletal Proteins; Diphtheria Toxoid; Disease Models, Animal; Disease Progression; Female; Gastrins; Gene Expression Regulation; Heterozygote; Immunization; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Omeprazole; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; RNA, Messenger; Survival Rate | 2001 |
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
Topics: Anastomosis, Surgical; Animals; Antimetabolites; Arteriosclerosis; Bromodeoxyuridine; Carotid Artery Diseases; Carotid Artery, Common; Carrier Proteins; Cell Cycle Proteins; Cell Division; Cholesterol, Dietary; Disease Progression; DNA Probes; DNA-Binding Proteins; E2F Transcription Factors; Genetic Therapy; Hypertrophy; Jugular Veins; Muscle, Smooth, Vascular; Proliferating Cell Nuclear Antigen; Rabbits; Retinoblastoma-Binding Protein 1; Transcription Factor DP1; Transcription Factors; Transfection; Tunica Intima; Up-Regulation | 2001 |
p53 and atherosclerosis.
Topics: Animals; Apolipoproteins E; Apoptosis; Arteriosclerosis; Bone Marrow Cells; Bromodeoxyuridine; Cell Division; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Foam Cells; In Situ Nick-End Labeling; Lipoproteins, LDL; Macrophages; Mice; Mice, Knockout; Mice, Mutant Strains; Muscle, Smooth, Vascular; Necrosis; Nitric Oxide; Nuclear Proteins; Phagocytosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2001 |
Promotion of chemically induced rat esophageal tumorigenesis with post-initiation ethanol modification.
Topics: Animals; Bromodeoxyuridine; Carcinogens; Cyclin D1; Dimethylnitrosamine; Disease Progression; Epithelium; Esophageal Neoplasms; Esophagus; Ethanol; Hyperplasia; Immunohistochemistry; Male; Rats; Rats, Inbred F344 | 2001 |
Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus.
Topics: Animals; Bromodeoxyuridine; Carotid Arteries; Carotid Stenosis; Catheterization; Cell Count; Cell Division; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Hyperplasia; Immunohistochemistry; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Tunica Intima; Vascular Patency | 2001 |
Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis.
Topics: Animals; Apoptosis; beta-Glucosidase; Blotting, Western; Bromodeoxyuridine; Cadherins; Carcinoma, Islet Cell; Cell Division; Disease Progression; DNA-Binding Proteins; Flow Cytometry; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Invasiveness; Pancreatic Neoplasms; Receptor, IGF Type 1; Signal Transduction; Transcription Factors; Up-Regulation | 2002 |